Carcinoma of the cervix

Carcinoma of the cervix is a malignancy arising from the cervix. It is the third most common gynaecologic malignancy (after endometrial and ovarian).

It typically presents in younger women with the average age of onset at around 45 years. 

Presenting symptoms include:

  • vaginal bleeding
  • vaginal discharge
  • subclinical: abnormal cervical cancer screening test

Invasive cervical carcinoma is thought to arise from the transformation of cervical intraepithelial neoplasia (CIN).

The main histological types are:

For a detailed overview, refer to:

Cervical squamous cell carcinoma arises from the squamocolumnar junction while adenocarcinomas arise from the endocervix. This is situated on the ectocervix in younger patients though regresses into the endocervical canal with age. Hence cervical tumours tend to be exophytic in younger patients and endophytic with advancing age.

In order to be radiographically visible, tumours must be at least stage Ib or above (see staging). MRI is the imaging modality of choice to depict the primary tumour and assess local extent. Distant metastatic disease is best assessed with CT or PET, where available.

Although the FIGO staging system is clinically based, the revised 2009 FIGO staging encourages imaging as an adjunct to clinical staging. MRI can stratify patients to the optimum treatment group of primary surgery or combined chemotherapy and radiotherapy. Tumours stage IIa and below are treated with surgery.

  • hypoechoic, heterogeneous mass involving the cervix
  • may show increased vascularity on colour Doppler
  • although cervical cancer is staged clinically, ultrasound can be a useful adjunct by showing
    • size (<4 cm or >4 cm)
    • parametrial invasion
    • tumour invasion into the vagina
    • tumour invasion into adjacent organs
    • hydronephrosis: implies stage IIIB tumour.

CT, in general, is not very useful in the assessment of the primary tumour, but it can be useful in assessing advanced disease. It is performed primarily to assess adenopathy, but also has roles in defining advanced disease, monitoring distant metastasis, planning the placement of radiation ports, and guiding percutaneous biopsy.

On CT, the primary tumour can be hypoenhancing or isoenhancing to normal cervical stroma (~50% 19). 

PET-CT in conjunction with pelvic MRI is often used as an imaging strategy in helping stage cervical carcinoma.  

A dedicated MRI protocol is often useful for optimal imaging assessment.

The normal low signal cervical stroma provides intrinsic contrast for the high signal cervical tumour.

  • T1: usually isointense compared with pelvic muscles
  • T2
    • hyperintense relative to the low signal of the cervical stroma
    • hyperintensity is thought to be present regardless of histological subtype 1
  • T1 C+ (Gd)
    • contrast is not routinely used, though it may be helpful to demonstrate small tumours considered for trachelectomy
    • on contrast-enhanced T1-weighted images, tumour presents as a high signal relative to the low signal of the cervical stroma 24

For further information, see the article: MRI reporting guidelines for cervical cancer.

The FIGO staging system is a most commonly adopted. See: cervical cancer staging

 Prognosis is affected by many factors which include:

  • tumour stage
  • volume of the primary mass
  • histologic grade

Five-year survival rates vary between 92% for stage I disease and 17% for stage IV disease 18.

One of the keys roles of the radiologist is to help determine staging, as this may lead to appropriate management pathway either with surgery or chemo-radiotherapy. At the time of writing stage IIa vs. IIb is considered as an important separator in deciding whether a case is operable or not.

For a mass involving the cervix consider:

  • MRI T2WI to assess parametrial invasion (stage 2b) is crucial to determine if the patient is candidate for surgery or not
Ultrasound - gynaecology
Share article

Article information

rID: 13318
Synonyms or Alternate Spellings:
  • Cervical cancer
  • Cervical carcinoma
  • Cancer of the cervix
  • Uterine cervical cancer
  • Uterine cervical carcinoma
  • Carcinoma of cervix
  • Carcinoma of the uterine cervix
  • Carcinoma of uterine cervix

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Case 1
    Drag here to reorder.
  • Drag
    Case 2
    Drag here to reorder.
  • Drag
     Case 3
    Drag here to reorder.
  • Drag
    Case 4
    Drag here to reorder.
  • Drag
    Case 5
    Drag here to reorder.
  • Drag
    Case 6: recurrence
    Drag here to reorder.
  • Drag
    Case 7
    Drag here to reorder.
  • Updating… Please wait.

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.